In about a month, Aurora Cannabis (TSX:ACB)(NYSE:ACB) is expected to release its quarterly results. Revenues are going to get a big boost from recreational sales, but it might not be enough to keep investors happy. The company announced this week that it expects to record between $50 million to $55 million in sales for the upcoming quarter. And while that’s a big improvement from the $12 million in sales that it brought in a year ago, it’s well short of expectations.
Analysts were forecasting as much as $67 million in sales for Q2. Depending on where Aurora’s final tally falls, it could be a miss of anywhere between 18% to 25%. That’s a significant miss for Wall Street, where companies can see their stocks punished by missing earnings by the narrowest of margins. A few months ago, rival Canopy recorded an even bigger sales miss in its quarterly results, which sent the struggling stock down even further.
The goods new, if you can call it that, is that Aurora’s stock was only down 4% on the news of its forecast for Q2. I say that’s good news only because another big earnings miss by a marijuana company could have sent investors into a panic. However, we’ll have to see in the coming days if there is more fallout from this, as it could be the start of a bigger sell-off.
Why does this matter?
The reason this is such a big deal is that pot stocks have long been soaring solely based on promises of future growth and the expectations that once the recreational market is legalized, sales will be unstoppable. Now, with the two biggest, most popular pot stocks in the country missing expectations significantly, investors are definitely going to be on high alert. Analysts may need to consider whether their estimates are too high for the industry.
And if estimates are too high, that means stock prices are as well, and we could see more corrections around the corner. It’s perhaps also a symptom of these stocks being listed on the big U.S. markets now and facing a lot more pressure and scrutiny from analysts.
The best case for the industry could be that these were one-off misses, and we’ll see the companies rebound in the following quarter. Worst case, however, is that these are warning signs that pot sales aren’t going to be as strong as expected, and that investors could be in for a rude awakening. While some people may scoff at this, saying that pot shops aren’t even open in Ontario and once edibles become legalized that sales will be fine, the analysts forecasting these results would have likely accounted for these items.
Aurora’s stock has declined by nearly 50% in the past three months, and this latest news could send it down even further. It’s further proof of how risky pot stocks are and why rising sales alone are not going to be enough to send them back up in price.
Just one ticking time bomb in your portfolio can set you back months – or years – when it comes to achieving your financial goals. There’s almost nothing worse than watching your hard-earned nest egg dwindle!
That’s why The Motley Fool Canada’s analyst team has put together this FREE investor brief, including the names and tickers of 3 TSX stocks they believe are set to LOSE you money.
Stock #1 is a household name – a one-time TSX blue chip that too many investors have left sitting idly in their accounts, hoping the company’s prospects will improve (especially after one more government bailout).
Still, our analysts rate this company a firm SELL.
Don’t miss out. Click here to see all three names right now.
Fool contributor David Jagielski has no position in any of the stocks mentioned.